- Home
- ORLY vs BMY Comparison
ORLY vs BMY Comparison
Compare ORLY & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLY
- BMY
- Stock Information
- Founded
- ORLY 1957
- BMY 1887
- Country
- ORLY United States
- BMY United States
- Employees
- ORLY N/A
- BMY N/A
- Industry
- ORLY Auto & Home Supply Stores
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- ORLY Consumer Discretionary
- BMY Health Care
- Exchange
- ORLY Nasdaq
- BMY Nasdaq
- Market Cap
- ORLY 79.9B
- BMY 94.0B
- IPO Year
- ORLY 1993
- BMY N/A
- Fundamental
- Price
- ORLY $96.98
- BMY $46.73
- Analyst Decision
- ORLY Strong Buy
- BMY Hold
- Analyst Count
- ORLY 17
- BMY 14
- Target Price
- ORLY $110.90
- BMY $57.54
- AVG Volume (30 Days)
- ORLY 5.8M
- BMY 16.6M
- Earning Date
- ORLY 10-22-2025
- BMY 10-30-2025
- Dividend Yield
- ORLY N/A
- BMY 5.32%
- EPS Growth
- ORLY 6.91
- BMY N/A
- EPS
- ORLY 2.88
- BMY 2.97
- Revenue
- ORLY $17,463,279,000.00
- BMY $48,034,000,000.00
- Revenue This Year
- ORLY $8.40
- BMY N/A
- Revenue Next Year
- ORLY $6.78
- BMY N/A
- P/E Ratio
- ORLY $33.00
- BMY $15.70
- Revenue Growth
- ORLY 6.19
- BMY 1.26
- 52 Week Low
- ORLY $78.30
- BMY $42.52
- 52 Week High
- ORLY $108.72
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- ORLY 44.63
- BMY 62.66
- Support Level
- ORLY $93.66
- BMY $45.38
- Resistance Level
- ORLY $96.38
- BMY $46.66
- Average True Range (ATR)
- ORLY 2.46
- BMY 1.01
- MACD
- ORLY 0.15
- BMY 0.40
- Stochastic Oscillator
- ORLY 59.63
- BMY 95.75
About ORLY O'Reilly Automotive Inc.
O'Reilly is an aftermarket automotive parts retailer in the United States and Mexico with more than $16 billion in annual sales. The company operates over 6,000 domestic stores and serves both the do-it-yourself (about 50% of sales) and professional (47% of sales) end markets. O'Reilly differentiates itself by providing quality service to its customers throughout the entirety of the vehicle diagnosis and purchasing process. Furthermore, the firm boasts an impressive hub-and-spoke distribution network designed to provide its localized store base with ample aftermarket part availability across a variety of vehicle makes and models.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.